Evidence map›Paper›PMID 26309029›Full record

ArticlePloS one2015

The Alpha-Melanocyte-Stimulating Hormone Suppresses TLR2-Mediated Functional Responses through IRAK-M in Normal Human Keratinocytes.

Sunhyo Ryu, Andrew Johnson, Yoonkyung Park, Beomjoon Kim, David Norris, Cheryl A Armstrong, Peter I Song

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 2 countries.

Sunhyo RyuDepartment of Dermatology, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado, United States of America; Department of Biotechnology, Chosun University School of Medicine, Gwangju, South Korea.
Andrew JohnsonDepartment of Dermatology, University of Arkansas for Medical Sciences, Little Rock, Arizona, United States of America.
Yoonkyung ParkDepartment of Biotechnology, Chosun University School of Medicine, Gwangju, South Korea.
Beomjoon KimDepartment of Dermatology, Chung-Ang University School of Medicine, Seoul, South Korea.
David NorrisDepartment of Dermatology, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado, United States of America.
Cheryl A ArmstrongDepartment of Dermatology, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado, United States of America; Division of Dermatology, Denver Health Medical Center, Denver, Colorado, United States of America.
Peter I SongDepartment of Dermatology, University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado, United States of America.
University of Colorado Denver · USChosun University · KRChung-Ang University · KRDenver Health Medical Center · USUniversity of Arkansas for Medical Sciences · USUniversity of Colorado Anschutz Medical Campus · US

Funding

Keratinocyte TLR in Cutaneous ImmunityR01AR052643 · NIAMS · UNIV OF ARKANSAS FOR MED SCIS · PI ARMSTRONG, CHERYL A · 2006 to 2010
$1.5M
NIAMS NIH HHS R01 AR052643
6 · The paper itself

Abstract

Alpha-melanocyte stimulating hormone (α-MSH) is a highly conserved 13-aa neuropeptide derived from pro-opiomelanocortin by post-translational processing, which has been reported to exhibit potent anti-inflammatory activity and a wide range of immunosuppressive activities in the skin. However, the regulatory effect of α-MSH is not completely clear in cutaneous innate immunity. In this study, we investigate the functional regulation of α-MSH in TLR2-mediated inflammatory responses in normal human keratinocytes (HKs). α-MSH pretreatment down-regulated the Staphylococcus aureus LTA-induced expression of both TLR2 and IL-8 as well as NF-κB nuclear translocation in HK cells. The inhibitory effect of α-MSH was blocked by agouti signaling protein (ASP), an α-MSH receptor-1 antagonist. To investigate the mechanism of this response in more detail, siRNA of IRAK-M, a negative regulator of TLR signaling, was utilized in these studies. The α-MSH suppressive effect on IL-8 production and NF-κB transactivation was inhibited by IRAK-M siRNA transfection in HK cells. These results indicate that α-MSH is capable of suppressing keratinocyte TLR2-mediated inflammatory responses induced by S. aureus-LTA, thus demonstrating another novel immunomodulatory activity of α-MSH in normal human keratinocytes.

Indexed as

Active Transport, Cell Nucleusalpha-MSHCell NucleusGene Expression Regulation, EnzymologicGene SilencingHumansInterleukin-1 Receptor-Associated KinasesInterleukin-8KeratinocytesLipopolysaccharidesNF-kappa BRNA, Small InterferingStaphylococcus aureusTeichoic AcidsToll-Like Receptor 2alpha-MSHInterleukin-1 Receptor-Associated KinasesInterleukin-8IRAK3 protein, humanLipopolysaccharideslipoteichoic acidNF-kappa BRNA, Small InterferingTeichoic AcidsTLR2 protein, humanToll-Like Receptor 2

Identifiers

PMID26309029
PMCPMC4550463
OpenAlexW1676515682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.